Healthcare Data and Analytics — Real-World Evidence, Population Health Management, and Claims Data Monetization

VPGMarketResearch
VP84694
$3,500.00

Healthcare data and analytics is one of the most commercially valuable and strategically contested segments in the healthcare industry. Payers, distributors, and pharmacy chains control vast repositories of claims data, pharmacy transaction data, and patient demographic data that are highly valuable to pharmaceutical manufacturers, medical device companies, researchers, and policymakers. UnitedHealth's Optum Insight — with $19.4 billion in 2025 revenue — is the most commercially advanced healthcare analytics business in the world. Real-world evidence generated from claims and EHR data is increasingly required by the FDA for drug approval, coverage decisions, and post-market surveillance.

This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.


Topics Covered
• Healthcare Analytics Market Dynamics
• Real-World Evidence Generation
• Population Health Management
• Claims Data Analytics
• Optum Insight, Evernorth, and Competitor Comparison
• Healthcare Data Privacy
• Analytics Monetization Models

Table of Contents
1. Executive Summary
2. Technology Landscape Overview
3. Healthcare Analytics Market Dynamics
4. Real-World Evidence Generation
5. Population Health Management
6. Claims Data Analytics
7. Optum Insight, Evernorth, and Competitor Comparison
8. Healthcare Data Privacy
9. Analytics Monetization Models
10. Competitive Landscape
11. Strategic Conclusions and Recommendations
12. Appendix

List of Tables
Table 1. Technology Overview and Key Data 2025
Table 2. Healthcare Analytics Market Dynamics
Table 3. Real-World Evidence Generation
Table 4. Population Health Management
Table 5. Claims Data Analytics
Table 6. Optum Insight, Evernorth, and Competitor Comparison
Table 7. Healthcare Data Privacy
Table 8. Analytics Monetization Models
Table 9. Leading Companies — Technology Investment and Strategy 2025
Table 10. M&A and Partnership Activity 2023-2025
Table 11. Key Risks and Mitigation Strategies


 

List of Figures
Figure 1. Technology Landscape Map 2025
Figure 2. Competitive Position Map 2025
Figure 3. Investment Activity 2020-2025
Figure 4. Adoption Trajectory 2025-2030
Figure 5. OEM Program Comparison 2025
Figure 6. Strategic Opportunity Framework


 

Companies Profiled
Arcadia
Health Catalyst
IBM
Inovalon
Optum
Oracle
Parexel
Veeva

$3,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838